MIRCERA.com

Elderly patients
No dosage adjustment is required in patients aged 65 years or older.

 

Children and adolescents
MIRCERA® is not recommended for use in children or adolescents younger than 18 years due to a lack of specific efficacy and safety data.

 

Pregnant women
There are no data from the use of MIRCERA in pregnant women. Animal studies do not indicate harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development but indicate a class-related reversible reduction in foetal weight. Caution should be exercised when prescribing to pregnant women.

 

Hepatic impaired patients
The safety and efficacy of MIRCERA therapy have not been established in patients with severe liver disease. Therefore, caution should be used in these patients.